A Centenary researcher is off to New Delhi to study the impact on cerebral malaria of the major ingredient of turmeric, curcumin. Dr Saparna Pai has been awarded an Australian Academy of Science Early-Career Australia-India Fellowship to investigate curcumin’s action on immune cells during malaria infection. The Fellowships were announced by the Academy during the…
Today is World Hepatitis Day and it brings good news and bad news. The bad news is that hepatitis is still a serious condition which affects nearly 400,000 Australians putting them on a course to serious liver disease. “The good news is that treatment is now less invasive, of shorter duration, much more effective—and diagnosis…
One large steppe for liver research Driving along the Pamir Highway in Tajikistan at 4000 m above sea level or through the Mongolian desert is a far cry from working on the genetics of hepatitis C in a laboratory in central Sydney. But that’s the transition Wil d’Avigdor, a PhD student from the Liver Injury…
After “astonishing” preliminary results from new drugs As the burden of Hepatitis C (HCV) associated liver failure and liver cancer rises in our community so hepatitis C therapy is undergoing radical and rapid change, says Centenary’s Prof Geoff McCaughan.
Australian and Vietnamese medical researchers are meeting in Sydney this week to plan their next move against tuberculosis (TB), a disease that once was Australia’s top killer and still kills 54,000 people each year in Vietnam. The researchers are coming together in Australia to share their progress and build stronger ties in fighting a disease…
TB used to be Australia’s top killer and in much of the world it still is. Australian experts available to talk about a scourge killing three people every minute.